Drug Company Profits Set to Increase from Additions to DSM-5 (LLY, NVS, PFE)
June 06, 2013 at 08:59 AM EDT
It’s a simple matter of math. The more diseases there are to treat, the more profit there is to be made – by drug companies that produce the medicines designed to treat those diseases. The Wall Street Journal reported Wednesday that the 5th edition of the Diagnostic and Statistic Manual
